|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||18.30 - 18.51|
|52 Week Range||16.61 - 21.00|
|Beta (5Y Monthly)||0.14|
|PE Ratio (TTM)||39.57|
|Forward Dividend & Yield||0.57 (3.12%)|
|Ex-Dividend Date||May 06, 2021|
|1y Target Est||N/A|
When Reckitt Benckiser acquired the baby formula maker Mead Johnson for £13bn four years ago, the consumer goods group’s then chief executive called it “an enriching solution for mums”. Now Laxman Narasimhan, Kapoor’s successor, is seeking to build on a pandemic surge in demand for Reckitt’s hygiene products to reinvigorate a company that some investors and analysts say has been harmed by the focus on integrating Mead Johnson.
U.K. consumer-goods giant Reckitt has struggled for years to make its baby-nutrition unit work in China. That is over now.
(Bloomberg) -- Reckitt Benckiser Group Plc agreed to sell its Chinese baby-formula business to Primavera Capital Group for $2.2 billion as the company seeks to exit from the struggling sector.Reckitt will retain an 8% stake in the unit and sees net cash proceeds of about $1.3 billion, which it plans to use to reduce debt, the company said in a statement on Saturday. The household-products maker, based in Slough in the U.K., expects to record a net loss of about £2.5 billion ($3.5 billion) relate